Literature DB >> 27889762

Evaluation of Isolation Methods for Circulating Tumor Cells (CTCs).

Galatea Kallergi1, Eleni Politaki, Saad Alkahtani, Christos Stournaras, Vassilis Georgoulias.   

Abstract

BACKGROUND: Detection of CTCs is a poor prognostic factor for many cancer types; however, their very low frequency represents an obstacle for their detection. The objective of the current study was to compare the performance of commonly used methods for CTCs isolation.
METHODS: The evaluated methods using spiking experiments of MCF7, SKBR3 and MDA MB-231 breast cancer cell lines were (i) ficoll density gradient separation (DGS), (ii) red blood cell lysis (Erythrolysis) isolation, (iii) positive immunomagnetic selection (EpCAM Dynal beads), (iv) two different negative immunomagnetic separation systems (Dynal vs Miltenyi CD45 beads) as well as (v) the Cell Search platform and (vi) the ISET system.
RESULTS: The recovery rates of Erythrolysis and DGS were 39% and 24%, respectively. Magnetic isolations are ranked from the worse to the best recovery rate as follows:, Myltenyi-anti-CD45 microbeads (24%); Dynal-anti-EpCAM beads (75%); Dynabeads-anti-CD45 (97%). CTCs isolation from blood samples using the CellSearch and ISET systems revealed that the recovery rate for Cell Search and ISET was 52% and 95%, respectively.
CONCLUSIONS: Dynal-anti-CD45 beads have the best recovery rate compared to other magnetic methods. Furthermore the recovery rate of ISET was higher compared to Cell Search, especially for the more aggressive MDA-MB 231 cell line.
© 2016 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27889762     DOI: 10.1159/000452556

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  23 in total

1.  Clinical significance of a pvrl 4 encoded gene Nectin-4 in metastasis and angiogenesis for tumor relapse.

Authors:  Chinmayee Sethy; Kunal Goutam; Deepika Nayak; Rajalaxmi Pradhan; Sefinew Molla; Subhajit Chatterjee; Niranjan Rout; Michael D Wyatt; Satya Narayan; Chanakya Nath Kundu
Journal:  J Cancer Res Clin Oncol       Date:  2019-10-15       Impact factor: 4.553

2.  Technical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor Invasion.

Authors:  Sophie Laget; Lucile Broncy; Katia Hormigos; Dalia M Dhingra; Fatima BenMohamed; Thierry Capiod; Magne Osteras; Laurent Farinelli; Stephen Jackson; Patrizia Paterlini-Bréchot
Journal:  PLoS One       Date:  2017-01-06       Impact factor: 3.240

3.  An integrated enrichment system to facilitate isolation and molecular characterization of single cancer cells from whole blood.

Authors:  Liping Yu; Silin Sa; Ling Wang; Keely Dulmage; Neha Bhagwat; Stephanie S Yee; Moen Sen; Charles H Pletcher; Jonni S Moore; Suraj Saksena; Eric P Dixon; Erica L Carpenter
Journal:  Cytometry A       Date:  2018-12       Impact factor: 4.355

4.  Continuous centrifugal microfluidics (CCM) isolates heterogeneous circulating tumor cells via full automation.

Authors:  Hyeong Jung Woo; Seung-Hoon Kim; Hyo Jung Kang; Soo-Hwan Lee; Seung Joon Lee; Jong Man Kim; Ogan Gurel; Soo Yeol Kim; Hye Ran Roh; Jungmin Lee; Yeonsoo Park; Hyun Young Shin; Yong-Il Shin; Sun Min Lee; So Yeon Oh; Young Zoon Kim; Jung-Il Chae; Seoyoung Lee; Min Hee Hong; Byoung Chul Cho; Eun Sook Lee; Klaus Pantel; Hye Ryun Kim; Minseok S Kim
Journal:  Theranostics       Date:  2022-05-01       Impact factor: 11.600

5.  Evaluation of Monocarboxylate Transporter 4 (MCT4) Expression and Its Prognostic Significance in Circulating Tumor Cells From Patients With Early Stage Non-Small-Cell Lung Cancer.

Authors:  Athina Markou; E Tzanikou; G Kallergi; E Pantazaka; V Georgoulias; A Kotsakis; E Lianidou
Journal:  Front Cell Dev Biol       Date:  2021-04-22

Review 6.  Promising Role of Circulating Tumor Cells in the Management of SCLC.

Authors:  Antonella De Luca; Marianna Gallo; Claudia Esposito; Alessandro Morabito; Nicola Normanno
Journal:  Cancers (Basel)       Date:  2021-04-22       Impact factor: 6.639

7.  Single-cell genetic analysis validates cytopathological identification of circulating cancer cells in patients with clear cell renal cell carcinoma.

Authors:  Lucile Broncy; Basma Ben Njima; Arnaud Méjean; Christophe Béroud; Khaled Ben Romdhane; Marius Ilie; Veronique Hofman; Jane Muret; Paul Hofman; Habiba Chaabouni Bouhamed; And Patrizia Paterlini-Bréchot
Journal:  Oncotarget       Date:  2018-04-13

8.  Role of regulatory T cells and CD8+ T lymphocytes in the dissemination of circulating tumor cells in primary invasive breast cancer.

Authors:  Dandan Xue; Tiansong Xia; Jue Wang; Meihong Chong; Shui Wang; Chunhui Zhang
Journal:  Oncol Lett       Date:  2018-06-19       Impact factor: 2.967

9.  Evaluation of PD-L1/PD-1 on circulating tumor cells in patients with advanced non-small cell lung cancer.

Authors:  Galatea Kallergi; Eleni-Kyriaki Vetsika; Despoina Aggouraki; Eleni Lagoudaki; Anastasios Koutsopoulos; Filippos Koinis; Panagiotis Katsarlinos; Maria Trypaki; Ippokratis Messaritakis; Christos Stournaras; Vassilis Georgoulias; Athanasios Kotsakis
Journal:  Ther Adv Med Oncol       Date:  2018-01-15       Impact factor: 8.168

10.  Polymer nanofiber-based microchips for EGFR mutation analysis of circulating tumor cells in lung adenocarcinoma.

Authors:  Wenting Jiang; Han Wang; Yongmei Cui; Yiyan Lei; Yuefeng Wang; Di Xu; Neng Jiang; Yangshan Chen; Yu Sun; Yang Zhang; Jessica Cao; Zunfu Ke
Journal:  Int J Nanomedicine       Date:  2018-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.